Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue.

Wolff EM, Chihara Y, Pan F, Weisenberger DJ, Siegmund KD, Sugano K, Kawashima K, Laird PW, Jones PA, Liang G.

Cancer Res. 2010 Oct 15;70(20):8169-78. doi: 10.1158/0008-5472.CAN-10-1335. Epub 2010 Sep 14.

2.

[Molecular changes in development and progression of urothelial carcinoma].

Hartmann A.

Verh Dtsch Ges Pathol. 2003;87:172-84. Review. German.

PMID:
16888910
3.

Biology of urothelial tumorigenesis: insights from genetically engineered mice.

Wu XR.

Cancer Metastasis Rev. 2009 Dec;28(3-4):281-90. doi: 10.1007/s10555-009-9189-4. Review.

4.

Bladder cancer, a two phased disease?

Höglund M.

Semin Cancer Biol. 2007 Jun;17(3):225-32. Epub 2006 Feb 28. Review.

PMID:
16574430
5.

Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.

Paner GP, Zehnder P, Amin AM, Husain AN, Desai MM.

Adv Anat Pathol. 2011 Jan;18(1):79-89. doi: 10.1097/PAP.0b013e318204c0cf. Review.

PMID:
21169741
6.

Genetic and molecular markers of urothelial premalignancy and malignancy.

Cordon-Cardo C, Cote RJ, Sauter G.

Scand J Urol Nephrol Suppl. 2000;(205):82-93. Review.

PMID:
11144907
7.

Molecular pathways of urothelial development and bladder tumorigenesis.

Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C.

Urol Oncol. 2010 Jul-Aug;28(4):401-8. doi: 10.1016/j.urolonc.2009.04.019. Review.

PMID:
20610278
8.

Epigenetic biomarkers in urothelial bladder cancer.

Kim WJ, Kim YJ.

Expert Rev Mol Diagn. 2009 Apr;9(3):259-69. doi: 10.1586/erm.09.5. Review.

PMID:
19379084
9.

Diagnosis and management of urothelial carcinoma of the bladder.

Tanaka MF, Sonpavde G.

Postgrad Med. 2011 May;123(3):43-55. doi: 10.3810/pgm.2011.05.2283. Review.

PMID:
21566415
10.

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.

Hafner C, Knuechel R, Stoehr R, Hartmann A.

Int J Cancer. 2002 Sep 1;101(1):1-6. Review.

11.

Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.

Arentsen HC, de la Rosette JJ, de Reijke TM, Langbein S.

Expert Rev Mol Diagn. 2007 Jan;7(1):11-9. Review.

PMID:
17187480
12.

Urothelial dysplasia of the bladder: diagnostic features and clinical significance.

Lopez-Beltran A, Montironi R, Vidal A, Scarpelli M, Cheng L.

Anal Quant Cytopathol Histpathol. 2013 Jun;35(3):121-9. Review.

PMID:
24344498
13.

Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.

Paner GP, Barkan GA, Mehta V, Sirintrapun SJ, Tsuzuki T, Sebo TJ, Jimenez RE.

Am J Surg Pathol. 2012 Mar;36(3):432-42. doi: 10.1097/PAS.0b013e31823fe49c. Review.

PMID:
22301493
14.

Urothelial carcinoma: stem cells on the edge.

Brandt WD, Matsui W, Rosenberg JE, He X, Ling S, Schaeffer EM, Berman DM.

Cancer Metastasis Rev. 2009 Dec;28(3-4):291-304. doi: 10.1007/s10555-009-9187-6. Review.

15.

Genetic and Epigenetic Alterations in Bladder Cancer.

Li HT, Duymich CE, Weisenberger DJ, Liang G.

Int Neurourol J. 2016 Nov;20(Suppl 2):S84-94. Epub 2016 Nov 22. Review.

Supplemental Content

Support Center